Inactive Instrument

CBA Florida Inc Share Price Other OTC

Equities

US21839P2065

Sales 2018 - Sales 2019 - Capitalization 9.54M 764M
Net income 2018 13M 1.04B Net income 2019 - 0 EV / Sales 2018 -
Net cash position 2018 12.41M 993M Net cash position 2019 11.53M 923M EV / Sales 2019 -
P/E ratio 2018
0.69 x
P/E ratio 2019
-268 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Cba Florida, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Cba Florida, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Cba Florida, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Cba Florida, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
Cba Florida, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Cba Florida, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Cord Blood America, Inc. will Change its Name to CBA Florida, Inc CI
Cord Blood America, Inc. Appoints Anthony Snow as President and Corporate Secretary CI
Cord Blood America, Inc. has Changed its Name to CBA, Inc CI
California Cryobank Stem Cell Services LLC completed the acquisition of all assets from Cord Blood America, Inc.. CI
Cord Blood America, Inc. Announces Financial Results for the First Quarter Ended March 31, 2018 CI
Cord Blood America, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2017 CI
California Cryobank Stem Cell Services LLC entered into an agreement acquire all assets from Cord Blood America, Inc. for $15.5 million. CI
Cord Blood America, Inc. Announces Financial Results for the Third Quarter Ended September 30, 2017 CI
Cord Blood America, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2017 CI
More news
Managers TitleAgeSince
President 49 14/04/15
Members of the board TitleAgeSince
Director/Board Member 59 28/02/06
Chairman 51 14/04/15
President 49 14/04/15
More insiders
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
Sector
-
More about the company